Body Mass Index at Presentation of Inflammatory Bowel Disease in Children
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: The evidence for an association between inflammatory bowel disease (IBD) and obesity is conflicting. Therefore, we set out to review the body mass index (BMI) at presentation of IBD to understand if the rise of the obesity rate in the general population, lead to an increase of obesity in patients with IBD at the time of diagnosis. Methods: Retrospective review of all patients with IBD seen at Children's Hospital and Medical Center from January 1st 2010 to December 31st 2014. From the initial visit and endoscopy, we obtained: age; sex; BMI; disease phenotype; disease severity. Results: We had a total of 95 patients, 35 patients were excluded due to incomplete data or referral being made after diagnosis was made. 28 were males and 32 were females, Age range was 2–17 years. A 37 had Crohn's disease, 19 ulcerative colitis, and 4 indeterminate colitis. Disease severity in 19 cases was mild, 29 moderate and 12 severe. BMI distribution was as follows—obese (5.0%), overweight (6.7%), normal weight (65.0%), mild malnutrition (8.3%), moderate malnutrition (15.0%), severe malnutrition (1.7%). Conclusion: Our data is consistent with other series. Showing most children had a normal BMI, regardless of disease severity or phenotypes. One confounding factor is the possibility of delay in referral to GI. This could mean some obese children may fall in the normal BMI range at the time of diagnosis due to ongoing weight loss. Future studies should include prospective cohort studies, comparing incidence of IBD in obese and non-obese patients, severity at presentation, duration of symptoms, and clinical outcomes.
Abstract
Purpose: The evidence for an association between inflammatory bowel disease (IBD) and obesity is conflicting. Therefore, we set out to review the body mass index (BMI) at presentation of IBD to understand if the rise of the obesity rate in the general population, lead to an increase of obesity in patients with IBD at the time of diagnosis. Methods: Retrospective review of all patients with IBD seen at Children's Hospital and Medical Center from January 1st 2010 to December 31st 2014. From the initial visit and endoscopy, we obtained: age; sex; BMI; disease phenotype; disease severity. Results: We had a total of 95 patients, 35 patients were excluded due to incomplete data or referral being made after diagnosis was made. 28 were males and 32 were females, Age range was 2–17 years. A 37 had Crohn's disease, 19 ulcerative colitis, and 4 indeterminate colitis. Disease severity in 19 cases was mild, 29 moderate and 12 severe. BMI distribution was as follows—obese (5.0%), overweight (6.7%), normal weight (65.0%), mild malnutrition (8.3%), moderate malnutrition (15.0%), severe malnutrition (1.7%). Conclusion: Our data is consistent with other series. Showing most children had a normal BMI, regardless of disease severity or phenotypes. One confounding factor is the possibility of delay in referral to GI. This could mean some obese children may fall in the normal BMI range at the time of diagnosis due to ongoing weight loss. Future studies should include prospective cohort studies, comparing incidence of IBD in obese and non-obese patients, severity at presentation, duration of symptoms, and clinical outcomes.
참고문헌 (27)
- Hales CM, "Prevalence of obesity among adults and youth: United States, 2015-2016", NCHS Data Brief, (288), pp.1~8 (2017)
- Versini M, "Obesity in autoimmune diseases : not a passive bystander", Autoimmun Rev, 13, pp.981~1000 (2014)
- Stofkova A, "Leptin and adiponectin : from energy and metabolic dysbalance to inflammation and autoimmunity", Endocr Regul, 43, pp.157~168 (2009)
- Iikuni N, "Leptin and inflammation", Curr Immunol Rev, 4, pp.70~79 (2008)
- Li L, "Adiponectin and interleukin-6 in inflammation-associated disease", Vitam Horm, 90, pp.375~395 (2012)
- Krysiak R, "The role of adipokines in connective tissue diseases", Eur J Nutr, 51, pp.513~528 (2012)
- Rosen MJ, "Inflammatory bowel disease in children and adolescents", JAMA Pediatr, 169, pp.1053~1060 (2015)
- Sýkora J, "Current global trends in the incidence of pediatric-onset inflammatory bowel disease", World J Gastroenterol, 24, pp.2741~2763 (2018)
- Miele E, "Nutrition in pediatric inflammatory bowel disease : a position paper on behalf of the Porto Inflammatory Bowel Disease Group of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition", J Pediatr Gastroenterol Nutr, 66, pp.687~708 (2018)
- Chan SS, "Body mass index and the risk for Crohn's disease and ulcerative colitis : data from a European Prospective Cohort Study(The IBD in EPIC Study)", Am J Gastroenterol, 108, pp.575~582 (2013)
- Seminerio JL, "Impact of obesity on the management and clinical course of patients with inflammatory bowel disease", Inflamm Bowel Dis, 21, pp.2857~2863 (2015)
- Hu Q, "The impact of obesity on the clinical course of inflammatory bowel disease : a meta-analysis", Med Sci Monit, 23, pp.2599~2606 (2017)
- Flores A, "Obesity in inflammatory bowel disease : a marker of less severe disease", Dig Dis Sci, 60, pp.2436~2445 (2015)
- Harper JW, "Interaction of obesity and inflammatory bowel disease", World J Gastroenterol, 22, pp.7868~7881 (2016)
- "Clinical growth charts, set 1: clinical charts with 5th and 95th percentiles" (2000)[URL]
- Himes JH, "Guidelines for overweight in adolescent preventive services: recommendations from an expert committee. The Expert Committee on Clinical Guidelines for Overweight in Adolescent Preventive Services", Am J Clin Nutr, 59, pp.307~316 (1994)
- Becker P, "Consensus statement of the Academy of Nutrition and Dietetics", American Society for Parenteral and Enteral Nutrition : indicators recommended for the identification and documentation of pediatric malnutrition(undernutrition), 2015, pp.30, 147~161
- Zwintscher NP, "Obesity has minimal impact on clinical outcomes in children with inflammatory bowel disease", J Pediatr Surg, 49, pp.265~268 (2014)
- Levine A, "ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents", J Pediatr Gastroenterol Nutr, 58, pp.795~806 (2014)
- Turner D, "Development, validation, and evaluation of a pediatric ulcerative colitis activity index : a prospective multicenter study", Gastroenterology, 133, pp.423~432 (2007)
- Hyams JS, "Development and validation of a pediatric Crohn's disease activity index", J Pediatr Gastroenterol Nutr, 12, pp.439~447 (1991)
- Kugathasan S, "Body mass index in children with newly diagnosed inflammatory bowel disease : observations from two multicenter North American inception cohorts", J Pediatr, 151, pp.523~527 (2007)
- Pituch-Zdanowska A, "Overweight and obesity in children with newly diagnosed inflammatory bowel disease", Adv Med Sci, 61, pp.28~31 (2016)
- Chandrakumar A, "Obesity is more common in children newly diagnosed with ulcerative colitis as compared to those with Crohn disease", J Pediatr Gastroenterol Nutr, 70, pp.593~597 (2020)
- El Mouzan MI, "Nutritional status of children with inflammatory bowel disease in Saudi Arabia", World J Gastroenterol, 22, pp.1854~1858 (2016)
- Wiskin AE, "Body composition in childhood inflammatory bowel disease", Clin Nutr, 30, pp.112~115 (2011)
- Reilly NR, "Celiac disease in normal-weight and overweight children : clinical features and growth outcomes following a gluten-free diet", J Pediatr Gastroenterol Nutr, 53, pp.528~531 (2011)